Victory Capital Management Inc Vbi Vaccines Inc Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$0.29 - $0.64 $7,887 - $17,407	27,199 New	27,199 $8,000
Q2 2021 Aug 03, 2021	SELL	$2.61 - $4.17 $190,477 - $304,326	-72,980 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$2.91 - $4.32 $3,035 - $4,505	-1,043 Reduced 1.41%	72,980 $227,000
Q4 2020 Feb 01, 2021	BUY	$2.15 - $3.5 $159,149 - $259,080	74,023 New	74,023 $204,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.